People · Operator
Named in public records as an officer, director or promoter · active 2015–2023 · Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sphero, Inc. | — | Other Technology | Series B | $114.2M | $4.8M | 2015 |
| Molekule Group, Inc. | — | Other Health Care | Series A | $25.0M | $72.7M | 2023 |
Brad M. Feld at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brad M. Feld on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brad Feld | 1 | 29 |
| Jason Mendelson | 1 | 19 |
| Mark Solon | 1 | 12 |
| Paul Berberian | 1 | 4 |
| Jason Schoettler | 1 | 4 |
| James M. Lejeal | 1 | 3 |
| Greg Warnock | 1 | 3 |
| Ritankar Pal | 1 | 2 |
| Michael J. Senft | 1 | 2 |
| Ian Bernstein | 1 | 2 |
| Jason DiBona | 1 | 2 |
| John Blood | 1 | 2 |
| Thomas P. McCaffrey | 1 | 2 |
| David J. Helfet | 1 | 2 |
| Jim Booth | 1 | 2 |
| Timothy J. Scannell | 1 | 2 |
| Stephen M. Ward | 1 | 2 |
| Amin J. Khoury | 1 | 2 |
| Greg M. Warnock | 1 | 1 |
| Paul A. Berberian | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.